Product
AJU-C52
1 clinical trial
1 indication
Indication
HypertensionClinical trial
A Randomized, Double-blind, Multi-center, Phase III Trial to Evaluate the Efficacy and Safety of AJU-C52 in Compared With C52R1M for Essential Hypertension Patients in Inappropriately Controlled on C52R1L TreatmentStatus: Recruiting, Estimated PCD: 2022-12-12